Tekla Capital Management LLC Novo Nordisk A S Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Tekla Capital Management LLC holds 122,777 shares of NVO stock, worth $12.5 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

122,777

Previous 111,323 10.29%

Holding current value

$12.5 Million

Previous $17.7 Million 12.16%

% of portfolio

0.79%

Previous 0.68%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $1.79 Million - $1.98 Million	11,454 Added 10.29%	122,777 $19.9 Million
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $2.54 Million - $3.06 Million	-19,200 Reduced 14.71%	111,323 $17.7 Million
Q2 2022 Jul 29, 2022	SELL	$103.24 - $121.81 $2.37 Million - $2.8 Million	-23,000 Reduced 14.98%	130,523 $14.5 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $3.27 Million - $3.96 Million	35,174 Added 29.72%	153,523 $17 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $2.17 Million - $2.65 Million	22,646 Added 23.66%	118,349 $13.3 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $3.99 Million - $5.04 Million	47,297 Added 97.71%	95,703 $9.19 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $1.11 Million - $1.25 Million	-16,500 Reduced 25.42%	48,406 $3.26 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $4.41 Million - $5.1 Million	-69,099 Reduced 51.56%	64,906 $4.53 Million
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $4.32 Million - $5.66 Million	-87,359 Reduced 39.46%	134,005 $8.07 Million
Q4 2019 Feb 13, 2020	SELL	$49.86 - $58.26 $979,050 - $1.14 Million	-19,636 Reduced 8.15%	221,364 $12.8 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $495,974 - $556,182	-10,600 Reduced 4.21%	241,000 $12.3 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $2.33 Million - $2.65 Million	-50,300 Reduced 16.66%	251,600 $13.2 Million
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $7.76 Million - $8.51 Million	166,000 Added 122.15%	301,900 $14.2 Million
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $6.59 Million - $7.9 Million	-135,900 Reduced 50.0%	135,900 $6.69 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $9.42 Million - $10.6 Million	198,200 Added 269.29%	271,800 $14.6 Million
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $5.91 Million - $7.07 Million	-143,700 Reduced 66.13%	73,600 $3.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	217,300	217,300 $9.32 Million

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Novo Nordisk A S Transaction History